Moderna

News

Vaccine vial dose flu shot drug needle syringe,medical concept vaccination hypodermic injection treatment disease care hospital prevention immunization illness disease baby child.blue background

FDA authorises COVID-19 booster jabs for at-risk people

The FDA has cleared the use of third dose of either the Pfizer/BioNTech or Moderna COVID-19 vaccines for people with weakened immune systems, but stopped short of recommending a broader boo

News

Moderna COVID-19 jab sales rocket to $4.2 billion in second ...

Moderna made a massive $4.2 billion from sales of just under 200 million doses of its COVID-19 vaccine, taking its tally since approval to around $6 billion from 302 million shots.

News

Close-up of the fag of Germany against a blue sky.

Germany confirms booster COVID jabs will start in September

Germany's health ministry has said it will start offering booster COVID-19 vaccines to vulnerable people from next month, amid concerns about rising cases of the delta variant of the corona

News

Resourceful or risky-The UKs controversial COVID-19 vaccine strategy

Study finds jabs cut severe variant COVID disease after one ...

A real-world study carried out in Canada has found that COVID-19 vaccines from AstraZeneca, Pfizer/BioNTech and Moderna reduce the chances of being hospitalised or dying from variants of co

News

Artifical intelegence DNA molecule. DNA is converted into a binary code. Concept binary code genome. Abstract technology science, concept artifical Dna, 3D illustration

Moderna plans triple vaccine targeting flu, COVID and RSV

Buoyed by the success of its COVID-19 vaccine, Moderna has started a phase 1/2 trials of its mRNA-based shot for seasonal influenza, targeting four different flu strains.

News

Moderna ramps up EU COVID jab capacity via Lonza deal

Capacity to supply Moderna's COVID-19 vaccine in Europe could be swelled by around 300 million doses a year, following an agreement to set up a new production line at contract manufacturer

FDA authorises COVID-19 booster jabs for at-risk people

Moderna COVID-19 jab sales rocket to $4.2 billion in second ...

Germany confirms booster COVID jabs will start in September

Study finds jabs cut severe variant COVID disease after one ...

Moderna plans triple vaccine targeting flu, COVID and RSV

Moderna ramps up EU COVID jab capacity via Lonza deal

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Moderna

Editor's Picks